Come and meet us at the Viral Safety for Biologics Congress – 27th to 28^h June 2012, Cologne, Germany

 

You'll have a clearer view on :

 

1. - Clean Cells' latest state of the art virus detection developments and others
2. - Regulatory requirements of the US, FDA, PEI, AFSSAPS and Korean FDA
3. - How interpreting data generated from next-generation detection technologies

 

 

 

 

This project aims to develop an assay that measures the standardized antibodies dependant cell mediated cytotoxicity activity (ADCC), usable by the biopharmaceutical industries in order to validate their therapeutic antibodies. This assay is recognized by the international regulatory agencies for lots release.

 

 

Please click here to know more on this collaborative project.

 

 They are talking about us - La Lettre API dated February 14 2012

 

 

Clean Cells is more than ever involved in the second generation therapies and wishes to share with its felow companies its latest scientific advances made on gene therapies.

We will be exhibiting with our partner the cGMP biopharmaceutical CMP GENIBET. 

Come and visit us at our stand N° 6 in London